Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Newswire Search Past 90 Days 10 stories 3 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View
Related Topics
Topic # Mentions Topic Reach
pharma8-
usfda5-
Prominent Journalists
Byline Articles Written Avg Reach
By PTI 3 -
KS Badri Narayanan 2 -
The Hindu Bureau 2 -
BL Bengaluru Bureau 1 -
By ANI 1 -
Dhanya Nagasundaram 1 -


Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observations
By PTI — thehindubusinessline.com


Q1 Results 4th Aug Live: Bharti Airtel, ONGC, Pidilite, Marico, Nykaa, Bharti Hexacom, NHPC, MCX, Godrej Properties, Kalyan Jewellers, Alembic, RITES, Zydus Wellness Q1 results today, Ather Energy, KEI, Sundaram Finance shares gain after Q1, DLF, UPL, Nazara, IREDA in red
KS Badri Narayanan — thehindubusinessline.com


Alembic Pharma gets U.S. FDA nod for generic chronic constipation drug
The Hindu Bureau — thehindu.com


Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%
Dhanya Nagasundaram — livemint.com


Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)
KS Badri Narayanan — thehindubusinessline.com


Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at $1.4 bn
By ANI — thehindubusinessline.com


Clinical investigator associated with study at Alembic’s bioequivalence unit gets U.S. FDA warning letter
The Hindu Bureau — thehindu.com


Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel
By PTI — thehindubusinessline.com


Alembic Pharma gets USFDA final approval for Oseltamivir oral suspension
BL Bengaluru Bureau — thehindubusinessline.com


Alembic Pharma gets tentative nod from USFDA for generic cancer drug
By PTI — thehindubusinessline.com

Execution: 1.43 Seconds. 61.1 mb used.